We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Eisai Asks Court to Compel DEA Scheduling of Fycompa
Eisai Asks Court to Compel DEA Scheduling of Fycompa
August 23, 2013
Ten months have passed since the FDA approved Eisai’s epilepsy drug Fycompa and the U.S. Drug Enforcement Administration has yet to initiate scheduling it, constituting “an unreasonable and egregious delay” that has fouled up time-sensitive marketing plans, the drugmaker said Aug. 19.